MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

immunotherapy

  • Scientists Discover Molecule That Prevents Immune System From Attacking Cancer Cells
    Scientists Discover Molecule That Prevents Immune System From Attacking Cancer Cells
    The findings offer potential for future research to improve the immune system's response against cancers.
    January 9, 2025BY Jerry Zhu
  • Common Immunotherapy Could Treat Heart Failure, Animal Study Finds
    Common Immunotherapy Could Treat Heart Failure, Animal Study Finds
    Scientists target scar tissue formation in a new heart failure treatment approach.
    October 23, 2024BY George Citroner
  • New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
    New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
    The treatment also showed a reduction in long-term side effects.
    October 16, 2024BY George Citroner
  • New Immunotherapy Shows Promise in Fighting Colon Cancer
    New Immunotherapy Shows Promise in Fighting Colon Cancer
    NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.
    August 7, 2024BY George Citroner
  • FDA Approves 1st T-Cell Therapy for Melanoma
    FDA Approves 1st T-Cell Therapy for Melanoma
    The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.
    February 20, 2024BY A.C. Dahnke
  • Cancer Patients With Mutated Mitochondria Respond Better to Treatment
    Cancer Patients With Mutated Mitochondria Respond Better to Treatment
    Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.
    January 30, 2024BY A.C. Dahnke
  • Can Cancer Kill Cancer?
    Can Cancer Kill Cancer?
    Yes, according to new research, where cancer cells were found to act as a ‘weapon’ against other cancer ...
    April 5, 2023BY Irina Antonova
  • The Best Time of Day for Cancer Treatment, as Shown by Studies
    The Best Time of Day for Cancer Treatment, as Shown by Studies
    Cancer cells can appear anywhere in our bodies at any time. Fortunately, they are almost always recognized and ...
    March 20, 2023BY Flora Zhao
  • CUHK Team Reveals Novel Cockroach Allergens, Helps Develop Precision Immunotherapy
    CUHK Team Reveals Novel Cockroach Allergens, Helps Develop Precision Immunotherapy
    Cockroach is the second most common allergen among Hongkongers suffering from allergic diseases such as asthma, allergic rhinitis, ...
    March 2, 2023BY Ying Cheung and Nathan Amery
  • New Treatment Regime for Metastatic NSC Lung Cancer Patients
    New Treatment Regime for Metastatic NSC Lung Cancer Patients
    Lung cancer is the leading cancer killer and the most common type of cancer in Hong Kong. In ...
    December 29, 2022BY Nathan Amery and Shan Lam
  • Study: Immune Anticancer Agents Can Increase the Risk of Diabetes
    Study: Immune Anticancer Agents Can Increase the Risk of Diabetes
    Immune anticancer agents are drugs that prevent cancer cells from evading the body's immune system or enable immune ...
    November 30, 2022BY Lisa Bian and Nathan Amery
  • Treatment Side Effects to Head and Neck Cancer Patients Reduced Using Immunotherapy
    Treatment Side Effects to Head and Neck Cancer Patients Reduced Using Immunotherapy
    Head and neck cancer patients suffer many side effects from conventional treatments, research shows such side effects can ...
    November 29, 2022BY Nathan Amery and Shan Lam
  • Lung Adenocarcinoma Symptoms Often Spotted at Late Stage, Treatment Options Available
    Lung Adenocarcinoma Symptoms Often Spotted at Late Stage, Treatment Options Available
    Lung cancer is the leading cause of cancer deaths, with the highest mortality worldwide. Specifically, adenocarcinoma is the ...
    November 20, 2022BY Jenny Han and Kang-Yun Lee
  • Certain Cancer Immunotherapy Treatments Impair Fertility: Study
    Certain Cancer Immunotherapy Treatments Impair Fertility: Study
    Australian researchers have found that some immunotherapy treatments for cancer can damage fertility, prompting a call for further ...
    August 29, 2022BY Steve Milne
  • New Finding Improves Response to Immunotherapy to Fight Tumours
    New Finding Improves Response to Immunotherapy to Fight Tumours
    Researchers from the University of Western Australia (UWA) and Olivia Newton-John Cancer Research Institute have discovered a new ...
    June 24, 2022BY Steve Milne
TOP NEWS
  • US Returns $12 Billion Collected From Venezuela’s Oil Sales This Year
    NEW By Jill McLaughlin
    US Returns $12 Billion Collected From Venezuela’s Oil Sales This Year
  • Senate Banking Chair Asks Ex-Nvidia CEO Huang, Commerce Chief Lutnick to Testify
    NEW By Kimberly Hayek
    Senate Banking Chair Asks Ex-Nvidia CEO Huang, Commerce Chief Lutnick to Testify
  • Van Hollen Challenges Schumer for Senate Majority Leader
    2hr By Joseph Lord
    Van Hollen Challenges Schumer for Senate Majority Leader
  • Day in Photos: Brooklyn Building Collapse, Heavy Rainfall in France, and Meteorite Exhibition
    3hr By Epoch Times Staff
    Day in Photos: Brooklyn Building Collapse, Heavy Rainfall in France, and Meteorite Exhibition
  • How Child Protective Services Are Allegedly Removing Kids From ‘Non-Affirming’ Parents | Laura Hanford
    4hr By Jan Jekielek, Epoch TV
    How Child Protective Services Are Allegedly Removing Kids From ‘Non-Affirming’ Parents | Laura Hanford
  • Blanche Says DOJ Has Not Confirmed If Ex-Nvidia CEO’s Affair Partner Was a Spy
    4hr By Jacki Thrapp
    Blanche Says DOJ Has Not Confirmed If Ex-Nvidia CEO’s Affair Partner Was a Spy
  • Hegseth Honors Sentinel Who Reprimanded Him and Aides at Tomb of the Unknown Soldier
    4hr By Timothy Frudd
    Hegseth Honors Sentinel Who Reprimanded Him and Aides at Tomb of the Unknown Soldier
  • New York City Investigating Brooklyn Building Collapse That Killed 8, Injured 18
    5hr By Nicholas Zifcak, Epoch Times
    New York City Investigating Brooklyn Building Collapse That Killed 8, Injured 18
  • Democrats’ Midterm Wins Encourage Activists at Climate Change Convention
    5hr By Kevin Stocklin
    Democrats’ Midterm Wins Encourage Activists at Climate Change Convention
  • Democrat Cindy Holscher Wins Kansas Governor’s Race
    6hr By Savannah Hulsey Pointer
    Democrat Cindy Holscher Wins Kansas Governor’s Race
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top